Uncategorized

China cools its growth in wealth products

  Bloomberg China’s boom in wealth-management products worth trillions of dollars, under scrutiny from regulators because of potential threats to financial stability, is slowing for now. Outstanding products issued by banks stood at 29.1 trillion yuan ($4.2 trillion) as of March 31, up 18.6 percent from a year earlier, according to the China Banking Regulatory Commission. The growth rate slumped ...

Read More »

Republican cracks emerge in Trump energy plan

  Bloomberg For all Donald Trump’s efforts to revive coal, market forces and some of his own supporters are vying to write their own version of America’s energy future. Divisions persist among the president’s supporters — and even within his own cabinet — about whether to continue subsidies for wind and solar power, enact a carbon tax, remain party to ...

Read More »

London house prices decline most in 8 years

  Bloomberg London house prices posted their largest annual drop in almost eight years in April as buyers shunned the capital’s central areas. The average asking price in the city fell 1.5 percent to 636,777 pounds ($813,000) this month from a year earlier, the largest annual decline since May 2009, property website Rightmove Plc said on Monday. On the month, ...

Read More »

Sprint looks beyond T-Mobile for deal options

  Bloomberg Wall Street is betting Sprint Corp. and T-Mobile US Inc. will soon revive talks on a blockbuster merger, but a recent surge in demand for wireless assets has Sprint exploring other ways to unleash value. Sprint’s parent SoftBank Group Corp. believes the company’s vast trove of wireless spectrum, which can be used for faster 5G services, has been ...

Read More »

Philips confident of sales growth

  Bloomberg Royal Philips NV said a strong order book and resilient performance in markets including China and India would allow the Dutch health-care equipment provider meet sales targets, even as uncertainty surrounding US policy led hospitals there to delay spending. The company reiterated a full-year revenue growth target of between 4 percent and 6 percent for its health technology ...

Read More »

ADM signs infrastructure pacts worth AED60 million

  Abu Dhabi / WAM Musabbah Mubarak Al Murar, Acting General Manager of Abu Dhabi City Municipality (ADM), signed two agreements with Emak Investment Group for the construction of two slipways for boats at Al Bahya and Al Sadr cities on the closing day of Cityscape 2017. He also signed a third agreement with Corner Stone Property Management LLC for building ...

Read More »

Global travel, tourism sector eyes Dubai as ATM kicks off

  Dubai / Emirates Business Travel trade professionals from across the world’s hospitality industry will descend upon Dubai on Monday for the opening of Arabian Travel Market (ATM) 2017, the region’s leading travel industry showcase. Simon Press, Senior Exhibition Director, ATM, said: “We have visitors registered from all corners of the globe and all facets of the hospitality industry for ...

Read More »

SCRF welcomes 110,000 visitors in first 4 days

  Sharjah / Emirates Business An impressive 110,000 people from around the region have stepped through the doors of the Expo Centre Sharjah during the first four action-packed days of the Sharjah Children’s Reading Festival (SCRF). The enormous variety of interactive activities, seminars, workshops and debates is drawing hoards of families and schoolchildren as well as renowned authors, historians, researchers ...

Read More »

Russia highlights country’s literature

  Sharjah / Emirates Business Celebrating Russia’s culture of literary genius and the outstanding titles that have enriched world literature, representatives from the Russian section of the International Board on Books for Young People (IBBY) have attended the Sharjah Children’s Reading Festival 2017 (SCRF) as the UAE Board on Books for Young People’s Guests of Honour. Russian representatives showcased and ...

Read More »

Samsung BioLogics in talks for 15 pharma contracts

  Bloomberg Samsung BioLogics Co., an arm of South Korea’s biggest conglomerate, said it is in negotiations to manufacture drugs for more than 15 international pharmaceutical companies as it tries to expand in the growing industry for complex biologic medicines. The talks mostly involve US and European firms, Chief Executive Officer Kim Tae-han said in an April 19 interview at ...

Read More »
Send this to a friend